Journal of Experimental & Clinical Cancer Research (Dec 2020)
Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells
- Cristina Alexandra Ciocan-Cartita,
- Ancuta Jurj,
- Oana Zanoaga,
- Roxana Cojocneanu,
- Laura-Ancuta Pop,
- Alin Moldovan,
- Cristian Moldovan,
- Alina Andreea Zimta,
- Lajos Raduly,
- Cecilia Pop-Bica,
- Mihail Buse,
- Liviuta Budisan,
- Piroska Virag,
- Alexandru Irimie,
- Sandra Martha Gomes Dias,
- Ioana Berindan-Neagoe,
- Cornelia Braicu
Affiliations
- Cristina Alexandra Ciocan-Cartita
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Ancuta Jurj
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Oana Zanoaga
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Roxana Cojocneanu
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Laura-Ancuta Pop
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Alin Moldovan
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Cristian Moldovan
- MedFuture Research Center for Advanced Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Alina Andreea Zimta
- MedFuture Research Center for Advanced Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Lajos Raduly
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Cecilia Pop-Bica
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Mihail Buse
- MedFuture Research Center for Advanced Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Liviuta Budisan
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Piroska Virag
- Laboratory of Radiotherapy, Radiobiology and Tumor Biology, “Prof. Dr. Ion Chiricuta” Oncology Institute
- Alexandru Irimie
- Department of Surgical Oncology and Gynecological Oncology, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Sandra Martha Gomes Dias
- Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas
- Ioana Berindan-Neagoe
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- Cornelia Braicu
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy
- DOI
- https://doi.org/10.1186/s13046-020-01789-3
- Journal volume & issue
-
Vol. 39,
no. 1
pp. 1 – 1
Abstract
An amendment to this paper has been published and can be accessed via the original article.
